Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) - Update 2008

M. Claudon; D. Cosgrove; T. Albrecht; L. Bolondi; M. Bosio; F. Calliada; J.-M. Correas; K. Darge; C. Dietrich; M. D’Onofrio; D. H. Evans; C. Filice; L. Greiner; K. Jäger; N. de Jong; E. Leen; R. Lencioni; D. Lindsell; A. Martegani; S. Meairs; C. Nolsøe; F. Piscaglia; P. Ricci; G. Seidel; B. Skjoldbye; L. Solbiati; L. Thorelius; F. Tranquart; H. P. Weskott; T. Whittingham

doi:10.1055/s-2007-963785

Ultraschall in der Medizin - European Journal of Ultrasound, Inhaltsverzeichnis

Ultraschall Med 2008; 29(1): 28-44
DOI: 10.1055/s-2007-963785

Guidelines

Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) - Update 2008

M. Claudon¹ , D. Cosgrove² , T. Albrecht³ , L. Bolondi⁴ , M. Bosio⁵ , F. Calliada⁶ , J.-M Correas⁷ , K. Darge⁸ , C. Dietrich⁹ , M. D’Onofrio¹⁰ , D. H. Evans¹¹ , C. Filice¹² , L. Greiner¹³ , K. Jäger¹⁴ , N. de Jong¹⁵ , E. Leen¹⁶ , R. Lencioni¹⁷ , D. Lindsell¹⁸ , A. Martegani¹⁹ , S. Meairs²⁰ , C. Nolsøe²¹ , F. Piscaglia²² , P. Ricci²³ , G. Seidel²⁴ , B. Skjoldbye²⁵ , L. Solbiati²⁶ , L. Thorelius²⁷ , F. Tranquart²⁸ , H. P. Weskott²⁹ , T. Whittingham³⁰

¹Department of Radiology, Nancy, France
²Imaging Sciences Department, Clinical Sciences Centre, Imperial College Hammersmith Hospital, London, UK
³Klinik für Radiologie und Nuklearmedizin, Campus Benjamin Franklin Charité - Universitätsmedizin Berlin; Freie Universität und Humboldt-Universität, Berlin, Germany
⁴Division of Internal Medicine Policlinico S. Orsola Malpighi, Bologna, Italy
⁵Paediatric Department, Magenta Hospital and Advanced School of Paediatric, Ultrasonography (S.I.U.M.B.), Magenta, Italy
⁶Istituto di Radiologia, Pavia, Italy
⁷Service de Radiologie, Hospital Necker, Paris, France
⁸Department of Pediatric Radiology, University Hospital, Wuerzburg, Germany
⁹Caritas-Krankenhaus, Bad Mergentheim, Germany
¹⁰Universita di Verona, Istituto di Radiologia, Verona, Italy
¹¹Department of Medical Physics, Leicester, UK
¹²Division of Infectious and Tropical Diseases, IRCCS S Matteo Hospital Pavia University School of Medicine, Pavia, Italy
¹³Helios Klinikum Wuppertal, Germany
¹⁴Universitätsspital, Basel, Switzerland
¹⁵Academisch Ziekenhuis, Rotterdam, Netherlands
¹⁶Clinical Sciences Centre, Imperial College London, UK
¹⁷Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants and Advanced Tecnologies in Medicine University of Pisa, Italy
¹⁸Department of Radiology, John Radcliffe Hospital Oxford, UK
¹⁹Servizio di Radiologia, Como. Italy
²⁰Neurologische Klinik, Universitätsklinikum Mannheim, Germany
²¹Department of Radiology, Køge Hospital, University of Copenhagen, Denmark
²²Spec. Medicina Interna. Dottore Di Recerca In Ultrasonologia in Medicina, Dirigente Medico I Livello, Bologna, Italy
²³Dipartimento Di Science Radiologiche Azienda Policlinico Umberto I, Roma, Italy
²⁴Department of Neurology University of Schleswig-Holstein, Lübeck, Germany
²⁵Herlev Hospital, Copenhagen University, Denmark
²⁶Department of Radiology, General Hospital of Busto Arsizio, Italy
²⁷Radiologisk Afdeling Herlev Hospital, Denmark
²⁸Unité Fonctionnelle Ultrasons Directeur CIT, Tour, France
²⁹Krankenhaus Siloah, Med. Klinik II, Hannover, Germany
³⁰Regional Medical Physics Dept, Newcastle General Hospital, UK

Abstract

Key words

contrast agent - liver - urinary - v. ureteric reflux - pancreas - trauma - transcranial US

Volltext

Referenzen

References

1 Tranquart F, Claudon M, Correas J M. Guidelines for the use of contrast agents in ultrasound. J Radiol. 2005; 86 1047-1054
2 Xiaoyan X, Guang H, Feng X. et al . Focal liver lesions ultrasound contrast: the light of the European Clinical Guide. China Ultrasound Imaging Magazine. 2006; 06 1-16
3 Bauer A, Solbiati L. Ultrasound contrast agents. Solbiati L Contrast-enhanced ultrasound of liver diseases Milan; Springer 2003: 21-26
4 Burns P. Contrast ultrasound technology. Solbiati L Contrast-enhanced ultrasound of liver diseases Milan; Springer 2003: 1-18
5 Correas J M, Bridal L, Lesavre A. et al . Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol. 2001; 11 1316-1328
6 Basilico R, Blomley M J, Harvey C J. et al . Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent?. Eur J Radiol. 2002; 41 184-191
7 Bernatik T, Becker D, Neureiter D. et al . Detection of liver metastases - comparison of contrast - enhanced ultrasound using first versus second generation contrast agents. Ultraschall in Med. 2003; 24 175-179
8 Leen E, Horgan P. Ultrasound contrast agents for hepatic imaging with nonlinear modes. Curr Probl Diagn Radiol. 2003; 32 66-87
9 Averkiou M, Powers J, Skyba D. et al . Ultrasound contrast imaging research. Ultrasound Q. 2003; 19 27-37
10 Burns P, Powers J, Hope Simpson D. et al . Harmonic Imaging: principles and preliminary results. Angiology. 1996; 47 S63-S74
11 Schrope B A, Newhouse V L. Second harmonic ultrasonic blood perfusion measurement. Ultrasound Med Biol. 1993; 19 567-579
12 Simpson D H, Chin C T, Burns P N. Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents. IEEE Trans on Ultrasonics, Ferroelectrics, and Freq Control. 1999; 46 372-382
13 Tiemann K, Lohmeier S, Kuntz S. et al . Real-Time Contrast Echo Assessment of Myocardial Perfusion at Low Emission Power: First Experimental and Clinical Results Using Power Pulse Inversion Imaging. Echocardiography. 1999; 16 799-809
14 Berrocal T, Gaya F, Arjonilla A. et al . Vesicoureteral reflux: diagnosis and grading with echo-enhanced cystosonography versus voiding cystourethrography. Radiology. 2001; 221 359-365
15 Darge K. Contrast-enhanced voiding urosonography for diagnosis of vesicoureteral reflux in children. Pediatr Radiol. 2007; 38 40-63
16 Darge K, Troeger J, Duetting T. et al . Reflux in young patients: comparison of voiding US of the bladder and retrovesical space with echo enhancement versus voiding cystourethrography for diagnosis. Radiology. 1999; 210 201-207
17 Ascenti G, Zimbaro G, Mazziotti S. et al . Harmonic US imaging of vesicoureteric reflux in children: usefulness of a second generation US contrast agent. Pediatr Radiol. 2004; 34 481-487
18 Bosio M, Xhepa R, Pandolfi M. Advancements in the diagnosis of vesico-ureteral reflux with cystourethrosonography (CUS): a comparative study between 1st and 2nd generation contrast media. Pediatr Nephrol. 2005; 20 C95
19 Darge K, Beer M, Gordjani N. et al . Contrast-enhanced voiding urosonography with the use of a 2nd generation US contrast medicum: preliminary results. Pediatr Radiol. 2004; 34 S97
20 Papadopoulou F, Katzioti F, Arkoumani E. et al . Voiding urosonography harmonic imaging with 2nd generation contrast agent for the diagnosis of reflux. Pediatr Radiol. 2005; 35 S31
21 Rehman S, Jayson G C. Molecular imaging of antiangiogenic agents. Oncologist. 2005; 10 92-103
22 Therasse P, Arbuck S G, Eisenhauer E A. et al . New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000; 92 205-216
23 World Health Organisation Offset Publication e .WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland; 1979
24 De Giorgi U, Aliberti C, Benea G. et al . Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors. Clin Cancer Res. 2005; 11 6171-6176
25 Lassau N, Lamuraglia M, Leclere J. et al . Functional and early evaluation of treatments in oncology: interest of ultrasonographic contrast agents. J Radiol. 2004; 85 704-712
26 Lassau N, Lamuraglia M, Chami L. et al . Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. AJR Am J Roentgenol. 2006; 187 1267-1273
27 Education and Practical Standards Committee, European Federation of Societies for Ultrasound in Medicine and Biology . Minimum training recommendations for the practice of medical ultrasound. Ultraschall in Med. 2006; 27 79-105
28 Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23 188 investigations. Ultrasound Med Biol. 2006; 32 1369-1375
29 Blomley M, Claudon M, Cosgrove D. WFUMB Safety Symposium on Ultrasound Contrast Agents: clinical applications and safety concerns. Ultrasound Med Biol. 2007; 33 180-186
30 Barnett S B, Duck F, Ziskin M. Recommendations on the safe use of ultrasound contrast agents. Ultrasound Med Biol. 2007; 33 173-174
31 Vancraeynest D, Kefer J, Hanet C. et al . Release of cardiac bio-markers during high mechanical index contrast-enhanced echocardiography in humans. Eur Heart J. 2007; 28 1236-1241
32 Kono Y, Steinbach G C, Peterson T. et al . Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: an intravital microscopy study in rats. Radiology. 2002; 224 253-257
33 Yanagisawa K, Moriyasu F, Miyahara T. et al . Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol. 2007; 33 318-325
34 Albrecht T, Blomley M J, Heckemann R A. et al . Stimulated acoustic emissions with the ultrasound contrast medium levovist: a clinically useful contrast effect with liver-specific properties. Fortschr Röntgenstr. 2000; 172 61-67
35 Blomley M J, Sidhu P S, Cosgrove D O. et al . Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? Early experience. Radiology. 2001; 220 661-667
36 Bryant T H, Blomley M J, Albrecht T. et al . Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study. Radiology. 2004; 232 799-809
37 Catala V, Nicolau C, Vilana R. et al . Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol. 2007; 17 1066-1073
38 Dietrich C, Ignee A, Trojan J. et al . Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut. 2004; 53 401-405
39 Dietrich C F, Ignee A, Frey H. Contrast-enhanced endoscopic ultrasound with low mechanical index: a new technique. Z Gastroenterol. 2005; 43 1219-1223
40 Dietrich C F, Mertens J C, Braden B. et al . Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology. 2007; 45 1139-1145
41 Dill-Macky M J, Burns P N, Khalili K. et al . Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology. 2002; 222 95-102
42 Ding H, Wang W P, Huang B J. et al . Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med. 2005; 24 285-297
43 Fan Z H, Chen M H, Dai Y. et al . Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology. AJR Am J Roentgenol. 2006; 186 1512-1519
44 Kim S H, Lee J M, Lee J Y. et al . Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis. AJR Am J Roentgenol. 2005; 184 1077-1084
45 Leen E, Ceccotti P, Kalogeropoulou C. et al . Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. AJR Am J Roentgenol. 2006; 186 1551-1559
46 Mork H, Ignee A, Schuessler G. et al . Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Scand J Gastroenterol. 2007; 42 652-662
47 Nicolau C, Vilana R, Catala V. et al . Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol. 2006; 186 158-167
48 Quaia E, Degobbis F, Tona G. et al . Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue. Radiol Med (Torino). 2004; 107 155-165
49 Quaia E, Stacul F, Bertolotto M. et al . Characterization of focal liver lesions with pulse inversion harmonic imaging (PIHI) using a second generation US contrast agent. Acad Radiol. 2002; 9 (Suppl 2) S376-379
50 Ricci P, Laghi A, Cantisani V. et al . Contrast-enhanced sonography with SonoVue: enhancement patterns of benign focal liver lesions and correlation with dynamic gadobenate dimeglumine-enhanced MRI. AJR Am J Roentgenol. 2005; 184 821-827
51 Strobel D, Hoefer A, Martus P. et al . Dynamic contrast-enhanced power Doppler sonography improves the differential diagnosis of liver lesions. Int J Colorectal Dis. 2001; 16 247-256
52 Herbay von A, Vogt C, Willers R. et al . Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med. 2004; 23 1557-1568
53 Wilson S R, Burns P N. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR Am J Roentgenol. 2006; 186 1401-1412
54 Wilson S R, Burns P N, Muradali D. et al . Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology. 2000; 215 153-161
55 Xu H X, Liu G J, Lu M D. et al . Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients. J Ultrasound Med. 2006; 25 349-361
56 Xu H X, Lu M D, Liu G J. et al . Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med. 2006; 25 23-33
57 Bolondi L, Gaiani S, Celli N. et al . Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology. 2005; 42 27-34
58 Celli N, Gaiani S, Piscaglia F. et al . Characterization of liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol. 2007; 19 3-14
59 Gaiani S, Celli N, Piscaglia F. et al . Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol. 2004; 41 421-426
60 Tarantino L, Francica G, Sordelli I. et al . Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging. 2006; 31 537-544
61 Venturi A, Piscaglia F, Silvagni E. et al . Role of real-time contrast-enhanced ultrasound in the assessment of metastatic portal vein thrombosis. Ultraschall in Med. 2007; 28 75-78
62 Beissert M, Jenett M, Keberle M. et al . Comparison of contrast harmonic imaging in B-mode with stimulated acoustic emission, conventional B-mode US and spiral CT in the detection of focal liver lesions. Fortschr Röntgenstr. 2000; 172 361-366
63 Konopke R, Kersting S, Bergert H. et al . Contrast-enhanced ultrasonography to detect liver metastases: A prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis. 2007; 22 201-207
64 Piscaglia F, Corradi F, Mancini M. et al . Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer. BMC Cancer. 2007; 7 171
65 Albrecht T, Blomley M J, Burns P N. et al . Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology. 2003; 227 361-370
66 Dietrich C F, Kratzer W, Strobe D. et al . Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol. 2006; 12 1699-1705
67 Harvey C J, Blomley M J, Eckersley R J. et al . Hepatic malignancies: improved detection with pulse-inversion US in late phase of enhancement with SH U 508A-early experience. Radiology. 2000; 216 903-908
68 Hohmann J, Albrecht T, Hoffmann C W. et al . Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. Eur J Radiol. 2003; 46 147-159
69 Leen E, Ceccotti P, Moug S J. et al . Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?. Ann Surg. 2006; 243 236-240
70 Torzilli G, Del Fabbro D, Palmisano A. et al . Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases. J Gastrointest Surg. 2005; 9 1148-1153; discussion 1153 - 1144
71 Livraghi T, Goldberg S N, Lazzaroni S. et al . Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology. 2000; 214 761-768
72 Livraghi T, Goldberg S N, Solbiati L. et al . Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology. 2001; 220 145-149
73 Oshowo A, Gillams A, Harrison E. et al . Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg. 2003; 90 1240-1243
74 Raut C P, Izzo F, Marra P. et al . Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol. 2005; 12 616-628
75 Rossi S, Di Stasi M, Buscarini E. et al . Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol. 1996; 167 759-768
76 Solbiati L, Livraghi T, Goldberg S N. et al . Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001; 221 159-166
77 Tateishi R, Shiina S, Teratani T. et al . Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer. 2005; 103 1201-1209
78 Choi D, Lim H K, Lee W J. et al . Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J Ultrasound Med. 2003; 22 1163-1172
79 Cioni D, Lencioni R, Rossi S. et al . Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power Doppler sonography to assess treatment outcome. AJR Am J Roentgenol. 2001; 177 783-788
80 Cova L, Solbiati L, Lerace T. Usefulness of contrast-enhanced ultrasonography and real-time low mechanical index harmonic imaging in the selection and monitoring of patients undergoing percutaneous radiofrequency thermal ablation of liver tumors. Eur Radiol. 2003; 13 S124
81 Dill-Macky M J, Asch M, Burns P. et al . Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography. AJR Am J Roentgenol. 2006; 186 S287-295
82 Minami Y, Kudo M, Kawasaki T. et al . Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol. 2004; 183 153-156
83 Morimoto M, Nozawa A, Numata K. et al . Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation. J Ultrasound Med. 2005; 24 273-283
84 Rhim H, Goldberg S N, Dodd G D. et al . Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics. 2001; 21 (Suppt 1) S17-S35; discussion S 36-S19
85 Solbiati L, Tonolini M, Lerace T. Guidance of percutaneous tumor ablation. Lencioni R Enhancing the role of ultrasound with contarst agents Heildelberg; Springer 2006: 69-76
86 Chen M H, Yang W, Yan K. et al . Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients - mathematic model, overlapping mode, and electrode placement process. Radiology. 2004; 232 260-271
87 Liu Z, Lobo S M, Humphries S. et al . Radiofrequency tumor ablation: insight into improved efficacy using computer modeling. AJR Am J Roentgenol. 2005; 184 1347-1352
88 Sasaki A, Kai S, Iwashita Y. et al . Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer. 2005; 103 299-306
89 Schmidt T, Hohl C, Haage P. et al . Diagnostic accuracy of phase-inversion tissue harmonic imaging versus fundamental B-mode sonography in the evaluation of focal lesions of the kidney. AJR Am J Roentgenol. 2003; 180 1639-1647
90 Robbin M L, Lockhart M E, Barr R G. Renal imaging with ultrasound contrast: current status. Radiol Clin North Am. 2003; 41 963-978
91 Ascenti G, Zimbaro G, Mazziotti S. et al . Usefulness of power Doppler and contrast-enhanced sonography in the differentiation of hyperechoic renal masses. Abdom Imaging. 2001; 26 654-660
92 Kim B, Lim H K, Choi M H. et al . Detection of parenchymal abnormalities in acute pyelonephritis by pulse inversion harmonic imaging with or without microbubble ultrasonographic contrast agent: correlation with computed tomography. J Ultrasound Med. 2001; 20 5-14
93 Israel G M, Bosniak M A. An update of the Bosniak renal cyst classification system. Urology. 2005; 66 484-488
94 Kim A Y, Kim S H, Kim Y J. et al . Contrast-enhanced power Doppler sonography for the differentiation of cystic renal lesions: preliminary study. J Ultrasound Med. 1999; 18 581-588
95 Claudon M, Barnewolt C E, Taylor G A. et al . Renal blood flow in pigs: changes depicted with contrast-enhanced harmonic US imaging during acute urinary obstruction. Radiology. 1999; 212 725-731
96 Claudon M, Plouin P F, Baxter G M. et al . Renal arteries in patients at risk of renal arterial stenosis: multicenter evaluation of the echo-enhancer SH U 508A at color and spectral Doppler US. Levovist Renal Artery Stenosis Study Group. Radiology. 2000; 214 739-746
97 Lencioni R, Pinto S, Cioni D. et al . Contrast-Enhanced Doppler Ultrasound of Renal Artery Stenosis: Prologue to a Promising Future. Echocardiography. 1999; 16 767-773
98 Melany M L, Grant E G, Duerinckx A J. et al . Ability of a phase shift US contrast agent to improve imaging of the main renal arteries. Radiology. 1997; 205 147-152
99 Correas J, Helenon O, Moreau J F. Contrast-enhanced ultrasonography of native and transplanted kidney diseases. Eur Radiol. 1999; 9 Suppl 3 S394-400
100 Schmiedl U P, Carter S, Martin R W. et al . Sonographic detection of acute parenchymal injury in an experimental porcine model of renal hemorrhage: gray-scale imaging using a sonographic contrast agent. AJR Am J Roentgenol. 1999; 173 1289-1294
101 Yamakado K, Tanaka N, Nakagawa T. et al . Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology. 2002; 225 78-82
102 Bosio M. Cystosonography with echocontrast: a new imaging modality to detect vesicoureteric reflux in children. Pediatr Radiol. 1998; 28 250-255
103 Galloy M A, Mandry D, Pecastaings M. et al . Sonocystography: a new method for the diagnosis and follow-up of vesico-ureteric reflux in children. J Radiol. 2003; 84 2055-2061
104 Kenda R B, Novljan G, Kenig A. et al . Echo-enhanced ultrasound voiding cystography in children: a new approach. Pediatr Nephrol. 2000; 14 297-300
105 Mentzel H J, Vogt S, Patzer L. et al . Contrast-enhanced sonography of vesicoureterorenal reflux in children: preliminary results. AJR Am J Roentgenol. 1999; 173 737-740
106 Radmayr C, Klauser A, Pallwein L. et al . Contrast enhanced reflux sonography in children: a comparison to standard radiological imaging. J Urol. 2002; 167 1428-1430
107 Uhl M, Kromeier J, Zimmerhackl L B. et al . Simultaneous voiding cystourethrography and voiding urosonography. Acta Radiol. 2003; 44 265-268
108 Valentini A L, De Gaetano A M, Destito C. et al . The accuracy of voiding urosonography in detecting vesico-ureteral reflux: a summary of existing data. Eur J Pediatr. 2002; 161 380-384
109 Vassiou K, Vlychou M, Moisidou R. et al . Contrast-enhanced sonographic detection of vesicoureteral reflux in children: comparison with voiding cystourethrography. Röntgenstr Fortschr. 2004; 176 1453-1457
110 Darge K, Ghods S, Zieger B. et al . Reduction in voiding cystourethrographies after the introduction of contrast enhanced sonographic reflux diagnosis. Pediatr Radiol. 2001; 31 790-795
111 Nakamura M, Shinozaki T, Taniguchi N. et al . Simultaneous voiding cystourethrography and voiding urosonography reveals utility of sonographic diagnosis of vesicoureteral reflux in children. Acta Paediatr. 2003; 92 1422-1426
112 Galia M, Midiri M, Pennisi F. et al . Vesicoureteral reflux in young patients: comparison of voiding color Doppler US with echo enhancement versus voiding cystourethrography for diagnosis or exclusion. Abdom Imaging. 2004; 29 303-308
113 Riccabona M, Mache C J, Lindbichler F. Echo-enhanced color Doppler cystosonography of vesicoureteral reflux in children. Improvement by stimulated acoustic emission. Acta Radiol. 2003; 44 18-23
114 Darge K, Trusen A, Gordjani N. et al . Intrarenal reflux: diagnosis with contrast-enhanced harmonic US. Pediatr Radiol. 2003; 33 729-731
115 Darge K, Zieger B, Rohrschneider W. et al . Contrast-enhanced harmonic imaging for the diagnosis of vesicoureteral reflux in pediatric patients. AJR Am J Roentgenol. 2001; 177 1411-1415
116 Kopitzko A, Cornely D, Reither K. et al . Low contrast dose voiding urosonography in children with phase inversion imaging. Eur Radiol. 2004; 14 2290-2296
117 Darge K, Bruchelt W, Roessling G. et al . Interaction of normal saline solution with ultrasound contrast medium: significant implication for sonographic diagnosis of vesicoureteral reflux. Eur Radiol. 2003; 13 213-218
118 Berrocal T, Gaya F, Arjonilla A. Vesicoureteral reflux: can the urethra be adequately assessed by using contrast-enhanced voiding US of the bladder?. Radiology. 2005; 234 235-241
119 Bosio M, Manzoni G A. Detection of posterior urethral valves with voiding cystourethrosonography with echo contrast. J Urol. 2002; 168 1711-1715; discussion 1715
120 Mate A, Bargiela A, Mosteiro S. et al . Contrast ultrasound of the urethra in children. Eur Radiol. 2003; 13 1534-1537
121 Darge K, Troeger J. Vesicoureteral reflux grading in contrast-enhanced voiding urosonography. Eur J Radiol. 2002; 43 122-128
122 Kenda R B. Imaging techniques for the detection of vesicoureteric reflux: what and when?. Nephrol Dial Transplant. 2001; 16 4-7
123 Riccabona M. Cystography in infants and children: a critical appraisal of the many forms with special regard to voiding cystourethrography. Eur Radiol. 2002; 12 2910-2918
124 D’Onofrio M, Mansueto G, Falconi M. et al . Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. Abdom Imaging. 2004; 29 246-258
125 D’Onofrio M, Zamboni G, Faccioli N. et al . Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging. 2007; 32 171-181
126 D’Onofrio M, Zamboni G, Malago R. et al .Pancreatic pathology. Quaia E Contrast media in ultrasonography Berlin; Springer-Verlag 2005: 335-247
127 Dietrich C F, Braden B, Hocke M. et al . Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound. J Cancer Res Clin Oncol. 2007 (in press);
128 D’Onofrio M, Martone E, Faccioli N. et al . Focal liver lesions: sinusoidal phase of CEUS. Abdom Imaging. 2006; 31 529-536
129 D’Onofrio M, Rozzanigo U, Masinielli B M. et al . Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography. J Clin Ultrasound. 2005; 33 164-172
130 Quaia E, D’Onofrio M, Palumbo A. et al . Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol. 2006; 16 1599-1609
131 Solbiati L, Tonolini M, Cova L. et al . The role of contrast-enhanced ultrasound in the detection of focal liver leasions. Eur Radiol. 2001; 11 (Suppl 3) E15-E26
132 D’Onofrio M, Malago R, Zamboni G. et al . Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology. 2005; 5 398-402
133 D’Onofrio M, Zamboni G, Tognolini A. et al . Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol. 2006; 12 4181-4184
134 Hocke M, Schulze E, Gottschalk P. et al . Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol. 2006; 12 246-250
135 Kitano M, Kudo M, Maekawa K. et al . Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut. 2004; 53 854-859
136 Masaki T, Ohkawa S, Amano A. et al . Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma. Cancer. 2005; 103 1026-1035
137 Numata K, Ozawa Y, Kobayashi N. et al . Contrast-enhanced sonography of pancreatic carcinoma: correlations with pathological findings. J Gastroenterol. 2005; 40 631-640
138 Rickes S, Wermke W. Differentiation of cystic pancreatic neoplasms and pseudocysts by conventional and echo-enhanced ultrasound. J Gastroenterol Hepatol. 2004; 19 761-766
139 Takeshima K, Kumada T, Toyoda H. et al . Comparison of IV contrast-enhanced sonography and histopathology of pancreatic cancer. AJR Am J Roentgenol. 2005; 185 1193-1200
140 Nagase M, Furuse J, Ishii H. et al . Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent. J Ultrasound Med. 2003; 22 789-795
141 D’Onofrio M, Megibow A J, Faccioli N. et al . Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses. AJR Am J Roentgenol. 2007; 189 1435-1442
142 Khan H G, Gailloud P, Bude R O. et al . The effect of contrast material on transcranial Doppler evaluation of normal middle cerebral artery peak systolic velocity. AJNR Am J Neuroradiol. 2000; 21 386-390
143 Seidel G, Kaps M. Harmonic imaging of the vertebrobasilar system. Stroke. 1997; 28 1610-1613

Prof. Michel CLAUDON

Department of Radiology, CHU de Nancy Brabois

Allée du Morvan

54511 Vandoeuvre les

Telefon: ++ 33/3/83 15 41 83

Fax: ++ 33/3/83 15 35 23

eMail: m.claudon@chu-nancy.fr